Cytokinetics | CYTK - EPS Earnings Per Share


Cytokinetics reported $-1.67 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 -1.67 -1.65 -1.36 May/05
FY2025Q4 Dec/2025 -1.50 -1.56 -1.26 Feb/24
FY2025Q3 Sep/2025 -2.55 -1.57 -1.36 Nov/05
FY2025Q2 Jun/2025 -1.12 -1.42 -0.08 Aug/07
FY2025Q1 Mar/2025 -1.36 -1.27 -1.33 May/06




Eps Change Date
Acadia Pharmaceuticals USD 0.02 1.58 Mar/2026
Amgen USD 5.15 0.14 Mar/2026
Arca Biopharma USD -0.54 0.14 Dec/2025
Bayer EUR 2.71 2.09 Mar/2026
Biogen USD 3.57 1.58 Mar/2026
Brainstorm Cell Therapeutics USD -0.19 0.15 Sep/2025
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Capricor Therapeutics USD -0.62 0.08 Dec/2025
Cytokinetics USD -1.67 0.17 Mar/2026
Eisai JPY -11.53 72.47 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Exelixis USD 0.87 0.1 Mar/2026
Geron USD -0.01 0.04 Mar/2026
Halozyme Therapeutics USD 1.6 1.84 Mar/2026
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
Ligand Pharmaceuticals USD 1.63 0.39 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Novartis USD 1.99 0.04 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Roche Holding CHF 8.37 2.95 Dec/2025
Sanofi EUR 1.88 0.35 Mar/2026